Gelteq (GELS) Liabilities and Shareholders Equity (2023 - 2025)

Gelteq's (GELS) quarterly Liabilities and Shareholders Equity came in at $13.2 million in Q4 2025, down 19.55% year-on-year from $16.4 million in Q4 2024, and down 3.92% quarter-over-quarter from $13.8 million in Q2 2025.

Gelteq (GELS) Liabilities and Shareholders Equity (2023 - 2025) Analysis & Trends

Gelteq's Liabilities and Shareholders Equity history runs 3 years deep, the most recent figure standing at $13.2 million for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 19.55% year-over-year to $13.2 million in Q4 2025; TTM through Dec 2025 was $57.1 million, a 26.44% increase from a year earlier, with the FY2025 full-year figure at $13.8 million, up 0.54% from the prior year.
  • Liabilities and Shareholders Equity slipped to $13.2 million in Q4 2025 per GELS's latest filing, from $13.8 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $16.4 million in Q4 2024 and bottomed at $13.2 million in Q4 2025.
  • The 3-year median for Liabilities and Shareholders Equity is $13.8 million (2025), against an average of $14.4 million.
  • Biggest YoY gain for Liabilities and Shareholders Equity was 0.54% in 2025; the steepest drop was 19.55% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $15.0 million in 2023, then gained by 9.24% to $16.4 million in 2024, then fell by 19.55% to $13.2 million in 2025.
  • Per Business Quant, the three latest GELS Liabilities and Shareholders Equity figures stand at $13.2 million (Q4 2025), $13.8 million (Q2 2025), and $16.4 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 43.40 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 40.04 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 15.15 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 98.91 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 6.71 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 69.30 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 36.83 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 4.91 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.22 Bn
10 Gelteq 740.00 -47,821.64 - 13.21 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 13.21 Mn
Jun 30, 2025 13.75 Mn
Dec 31, 2024 16.42 Mn
Jun 30, 2024 13.68 Mn
Jun 30, 2023 15.03 Mn